Cogent Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2017 | 52.2% | 52.2% | -51.9% |
| FY2018 | -57.3% | -57.3% | -40.2% |
| FY2019 | -100.2% | -100.2% | -64.4% |
| FY2020 | -31.9% | -31.9% | -29.8% |
| FY2021 | -33.7% | -33.7% | -31.1% |
| FY2022 | -54.8% | -54.8% | -46.6% |
| FY2023 | -74.6% | -74.6% | -61.4% |
| FY2024 | -99.8% | -99.8% | -78.0% |
| FY2025 | -51.7% | -38.3% | -35.1% |